Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.

Chen G, Ni Y, Nagata N, Xu L, Ota T.

Int J Mol Sci. 2016 Aug 23;17(9). pii: E1379. doi: 10.3390/ijms17091379. Review.

2.

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer.

Asgharpour A, Cazanave SC, Pacana T, Seneshaw M, Vincent R, Banini BA, Kumar DP, Daita K, Min HK, Mirshahi F, Bedossa P, Sun X, Hoshida Y, Koduru SV, Contaifer D Jr, Warncke UO, Wijesinghe DS, Sanyal AJ.

J Hepatol. 2016 Sep;65(3):579-88. doi: 10.1016/j.jhep.2016.05.005. Epub 2016 May 31.

3.

Role of Serum Biomarkers in Early Detection of Non-Alcoholic Steatohepatitis and Fibrosis in West Virginian Children.

Sodhi K, Bracero L, Feyh A, Nichols A, Srikanthan K, Latif T, Preston D, Shapiro JI, Elitsur Y.

J Clin Cell Immunol. 2016 Feb;7(1). pii: 393. Epub 2016 Feb 17.

4.

Autophagy: a new target for nonalcoholic fatty liver disease therapy.

Mao Y, Yu F, Wang J, Guo C, Fan X.

Hepat Med. 2016 Mar 24;8:27-37. doi: 10.2147/HMER.S98120. eCollection 2016 Mar 24. Review.

5.
6.

Function of Autophagy in Nonalcoholic Fatty Liver Disease.

Czaja MJ.

Dig Dis Sci. 2016 May;61(5):1304-13. doi: 10.1007/s10620-015-4025-x. Epub 2016 Jan 2.

PMID:
26725058
7.

Macrophage autophagy limits acute toxic liver injury in mice through down regulation of interleukin-1β.

Ilyas G, Zhao E, Liu K, Lin Y, Tesfa L, Tanaka KE, Czaja MJ.

J Hepatol. 2016 Jan;64(1):118-27. doi: 10.1016/j.jhep.2015.08.019. Epub 2015 Aug 29.

8.

Cross talk of the immune system in the adipose tissue and the liver in non-alcoholic steatohepatitis: Pathology and beyond.

Vonghia L, Francque S.

World J Hepatol. 2015 Jul 28;7(15):1905-12. doi: 10.4254/wjh.v7.i15.1905.

9.

Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Spengler EK, Loomba R.

Mayo Clin Proc. 2015 Sep;90(9):1233-46. doi: 10.1016/j.mayocp.2015.06.013. Epub 2015 Jul 26. Review.

10.

Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.

Nozaki Y, Fujita K, Wada K, Yoneda M, Kessoku T, Shinohara Y, Imajo K, Ogawa Y, Nakamuta M, Saito S, Masaki N, Nagashima Y, Terauchi Y, Nakajima A.

BMC Gastroenterol. 2015 Apr 1;15:42. doi: 10.1186/s12876-015-0269-3.

11.

Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis.

Le TA, Loomba R.

J Clin Exp Hepatol. 2012 Jun;2(2):156-73. doi: 10.1016/S0973-6883(12)60104-2. Epub 2012 Jul 21.

12.

Complement alternative pathway activation in human nonalcoholic steatohepatitis.

Segers FM, Verdam FJ, de Jonge C, Boonen B, Driessen A, Shiri-Sverdlov R, Bouvy ND, Greve JW, Buurman WA, Rensen SS.

PLoS One. 2014 Oct 9;9(10):e110053. doi: 10.1371/journal.pone.0110053. eCollection 2014 Oct 9.

13.

Role of liver biopsy in nonalcoholic fatty liver disease.

Nalbantoglu IL, Brunt EM.

World J Gastroenterol. 2014 Jul 21;20(27):9026-37. doi: 10.3748/wjg.v20.i27.9026. Review.

14.

β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.

Kobori M, Ni Y, Takahashi Y, Watanabe N, Sugiura M, Ogawa K, Nagashimada M, Kaneko S, Naito S, Ota T.

PLoS One. 2014 May 23;9(5):e98294. doi: 10.1371/journal.pone.0098294. eCollection 2014 May 23.

15.

Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death.

Tang T, Sui Y, Lian M, Li Z, Hua J.

PLoS One. 2013 Dec 3;8(12):e81949. doi: 10.1371/journal.pone.0081949. eCollection 2013 Dec 3.

16.

CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

Najjar SM, Russo L.

Semin Immunopathol. 2014 Jan;36(1):55-71. doi: 10.1007/s00281-013-0407-3. Epub 2013 Nov 21. Review.

17.

Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis.

Vonghia L, Michielsen P, Francque S.

Int J Mol Sci. 2013 Oct 1;14(10):19867-90. doi: 10.3390/ijms141019867. Review.

18.

What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Scalera A, Di Minno MN, Tarantino G.

World J Gastroenterol. 2013 Sep 7;19(33):5402-20. doi: 10.3748/wjg.v19.i33.5402. Review.

19.

Mice lacking C1q are protected from high fat diet-induced hepatic insulin resistance and impaired glucose homeostasis.

Hillian AD, McMullen MR, Sebastian BM, Roychowdhury S, Kashyap SR, Schauer PR, Kirwan JP, Feldstein AE, Nagy LE.

J Biol Chem. 2013 Aug 2;288(31):22565-75. doi: 10.1074/jbc.M113.465674. Epub 2013 Jun 20. Erratum in: J Biol Chem. 2013 Sep 27;288(39):28308. Rowchowdhury, Sanjoy [corrected to Roychowdhury, Sanjoy].

20.

Functions of autophagy in normal and diseased liver.

Czaja MJ, Ding WX, Donohue TM Jr, Friedman SL, Kim JS, Komatsu M, Lemasters JJ, Lemoine A, Lin JD, Ou JH, Perlmutter DH, Randall G, Ray RB, Tsung A, Yin XM.

Autophagy. 2013 Aug;9(8):1131-58. doi: 10.4161/auto.25063. Epub 2013 May 22. Review.

Supplemental Content

Support Center